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Abstract 
Objective: To analyze hyperlipidemia patterns among newly diagnosed young diabetic patients.  
Study Design: A descriptive cross-sectional study. Place and Duration: Study was conducted in Nawaz Shareef 
Medical College and Rawalpindi Medical University from Jan 2017 and Jan 2018. Methodology:  All the 
patients were young and newly diagnosed with Diabetes Mellitus. Data collection was done via non probability 
consecutive sampling included patients’ demographics, past medical history, co-morbidities, and lab findings 
were assessed. SPSS version 24 was used to analyze data. P value ≤ 0.05 was taken as significant. Results: 
Eighty patients were included in this study. Diabetic nephropathy, diabetic retinopathy, macrovascular 
complications, hyperglycemic hyperosmolar non-ketotic coma history, family history and hypertension were 
noted in n=12 (15%), n=6 (7.5%), n=9 (11.3%), n=1 (1.3%), n=34 (42.5%) and n=11 (13.8%) respectively. The 
mean hyperlipidemia, hypertriglyceridemia, of the patients was 4.54±0.52 mmol/L, 2.59±1.13 mmol/L, 
1.39±0.80 mmol/L, 1.03±0.59 mmol/L respectively. Conclusion: the study has shown that the prevalence of 
increased levels of triglycerides is more than increased LDL cholesterol levels among these patients. As it has 
been established that hypertriglyceridemia is a known risk factor for causing cardiovascular disorders among 
diabetic patients, it should be addressed and managed accordingly at the onset of diabetes.  
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Introduction 
One of the leading causes of chronic morbidity and mortality is Diabetes mellitus 1. Its prevalence is 
mushrooming many times in south Asia.  Various factors contribute to this metabolic disorder including BMI, 
higher degree of genetic predisposition, increased levels of insulin resistance, and increased susceptibility to 
environmental insulin 2. There is absolute deficiency of insulin secretion, action of insulin in relation to 
hyperglycemia, protein metabolism as well carbohydrate and lipids are deranged 3. Various studies have shown 
that components of body composition such aa body fat and lipid profile are the culprits of increased prevalence 
of this disease. The abnormalities of lipid metabolism are more profound in diabetes mellitus as the pathway of 
lipid metabolism is influenced by deficiency and secretion of insulin 4. Dyslipidemia is considered as a major 
risk factor in inducing cardiovascular diseases in diabetics. Increased triglycerides and LDL and decreased HDL 
lipoproteins are the main features of diabetic dyslipidemia 5. In diabetic patients, the prevalence of 
hypercholesterolemia is not enhanced whereas the risk of mortality from coronary artery disease is increased 6.  
The guidelines from American Diabetic Association suggests stabilizing the serum triglycerides levels 
less than 150mg/dL, LDL levels less than 100mg/dL and HDL greater than 40mg/dL in males while 50mg/dL in 
females 7. The changes in lifestyle has made this situation indicated. It is to be kept in mind that metabolic 
derangements produced are reversible and preventable 8.  
In Pakistan, 7.1 million people are suffering from diabetes mellitus 9. There is a prevalence rate of 18-
46%. A special triad of symptomology seen more often is the hyperlipidemia, coronary artery disease. It 
enhances the severity of coronary artery disease 10. Hence, this study was put forth to analyze the frequency of 
hypertriglyceridemia, and hyperlipidemia patterns in young patients that are recently diagnosed with diabetes 
mellitus. 
Methodology 
The study took place at Study was conducted Study was conducted in Nawaz Shareef Medical College and 
Rawalpindi Medical University from Jan 2017 and Jan 2018. The included participants were all newly 
diagnosed. Informed consent was taken from the patients and approval from ethics committee was taken. Data 
collection was done via consecutive sampling. It included patients’ demographics, past medical history, co-
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morbidities, and lab findings. Fasting glucose levels were collected and viewed for LDL, Triglycerides and total 
cholesterol levels. The duration of fasting was minimum of 9 hours and maximum of 12 hours. The patients 
using lipid lowering agents or the ones who were having dietary restriction as well as obese patients were 
excluded from the study. Patients using beta blockers or diuretics and alcoholic patients were also excluded from 
the study. Triglycerides were termed high in the presence of greater than 1.7mmol/L and high LDL was 
determined at a level of 2.59mmol/L. the analysis of data was done through SPSS version 23.  
Results 
 Eighty patients were included in this study. The mean age of the patients was 38.28±4.37 years. 
Diabetic nephropathy, diabetic retinopathy, macrovascular complications, hyperglycemic hyperosmolar non-
ketotic coma history, family history and hypertension were noted in n=12 (15%), n=6 (7.5%), n=9 (11.3%), n=1 
(1.3%), n=34 (42.5%) and n=11 (13.8%) respectively. Diabetes was noted type-I and type-II as n=28 (35%) and 
n=52 (65%) respectively. Proteinuria was observed trace, +1 and +2 as n=66 (82.5%), n=10 (12.5%) and n=4 
(5%) respectively. (Table. I).  
  The mean hyperlipidemia, hypertriglyceridemia, LDL, HDL, urea, creatinine, HbA1C, ALT, BSF and 
BSR of the patients was 4.54±0.52 mmol/L, 2.59±1.13 mmol/L, 1.39±0.80 mmol/L, 1.03±0.59 mmol/L, 
3.08±1.42 mmol/L, 97.23±4.82 μmol/L, 8.55±1.05 mmol/L, 49.50±2.85 units/L, 200.40±5.16 mg/dL and 
313.78±7.32 mg/dL respectively.  (Table. II). 
Table. I 
 
 
Table. II 
 
 
 
 
 
 
 
 
Discussion 
One of the most common chronic diseases is diabetes mellitus which ranks among the top five causes of 
mortality around the world, says Padmini O et al 11. it is said to be equivalent to coronary heart disease in terms 
of risk factor for causing cardiovascular complications. A major known risk factor for these vascular 
Variables Presence 
Age 38.28±4.37 
Diabetic nephropathy n=12 (15%) 
Diabetic retinopathy n=6 (7.5%) 
Macrovascular Complications n=9 (11.3%) 
Hyperglycemic Hyperosmolar Non-
ketotic Coma history 
n=1 (1.3%) 
Family History n=34 (42.5%) 
Hypertension n=11 (13.8%) 
Diabetes 
Type-I n=28 (35%) 
Type-II n=52 (65%) 
Proteinuria 
Trace n=66 (82.5%) 
+1 n=10 (12.5%) 
+2 n=4 (5%) 
Variables Mean±S.D 
Hyperlipidemia (mmol/L) 4.54±0.52 
Hypertriglyceridemia (mmol/L)  2.59±1.13 
LDL (mmol/L) 1.39±0.80 
HDL (mmol/L) 1.03±0.59 
Urea (mmol/L) 3.08±1.42 
Creatinine (μmol/L) 97.23±4.82 
HbA1C (mmol/L) 8.55±1.05 
ALT (units/L) 49.50±2.85 
BSF (mg/dL) 200.40±5.16 
BSR (mg/dL) 313.78±7.32 
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complications is dyslipidemia. Hence a study was done to prove the strong association between Dyslipidemias 
and Diabetes mellitus type 2. It was a one-year cross sectional prospective study upon 100 patients proving that 
there is remarkably significant and hence considerable association of dyslipidemia with Diabetes Mellitus type 2. 
A hypothesis was made suggesting the interrelationship of transmembrane transport of cholesterol is 
related to the development of type 2 diabetes by Besseling J et al 12. hence the association between diabtes type 2 
and familial hypercholesterolemia was testes in a cross-sectional study where the DNA testing of all patients was 
done. The study demonstrated that prevalence of diabetes mellitus type 2 in patients having familial 
hypercholesterolemia was found to be markedly reduced than was found between unaffected relatives with some 
variation due to type of mutation. If this association is confirmed in further longitudinal analysis, it will rise the 
suspicion of causal relation between LDL receptor mediated transmembrane cholesterol transport and diabetes 
type 2.  
As dyslipidemia is a known risk factor for coronary artery disease in type 2 diabetes mellitus, a post hoc 
analysis was done by Watts GF 13 in diabetic patients. The analysis of lipid regulating trials demonstrated that 
increase in serum HDL with a decrease in LDL along with a statin or rise in serum HDL with decrease in 
triglycerides with a fibrate reduces the risk of incidence of coronary diseases. This absolute reduction is high 
enough to make lipid lowering therapy cost effective among these patients. Hence ameliorating the 
dyslipidemias, improves the outcome of coronary diseases and reduces the risk of their occurrence.   
When patterns of dyslipidemia were observed in patients of Lahore having Diabetes mellitus by Naheed 
T et al 14, it was seen that among patients having diabetes for less than ten years, the level of serum cholesterol 
was 191.72±5.72whereas it was found to be 213.11±6.70in patients having diabetes for more than 10 years. The 
level of serum triglyceride among patients with shorter duration of diabetes was 191.83 ± 8.05 and HDL level 
was 36.25±0.45 and LDL was 127.1±3.99. among patients having diabetes for longer duration >10 years, 
triglycerides were 210.04±8.90and HDL was 35.57±0.60 and LDL was 147.5±5.20. out of 100 patients, 58 
patients had hypertension. It is observed that the duration of diabetes affects greatly the incidence of 
dyslipidemia.  
The major cause of morbidity and mortality in patients with diabetes mellitus is cardiovascular diseases 
15. The known risk factors proceed the same way in both diabetic and non-diabetics, thus the reasonable 
explanation have been made for increased atherothrombosis in diabetes mellitus type 2. Among the 
characteristics known for diabetes mellitus type 2, one recently focused factor in research is hyperglycemia. It 
has found that even in the absence of diabetes mellitus, the increased glucose levels are associated with higher 
risk of cardiovascular diseases. It has been shown by various studies that include diabetics and non-diabetics that 
hyperglycemia can’t be ignored as risks factor for cardiovascular diseases, as said by Laakso M 16. The harmful 
effects of glucose begin to produce their effects at the glucose range of <6.1 mmol/l. whereas in diabetes, the 
effect of hyperglycemia works in an exponential manner. It has been established that long term complications of 
diabetes can be prevented by good glycemic control. Similarly, intensive treatment of hypertension and 
hypercholesterolemia in patients with diabetes also improves the outcomes.  
There are various studies showing the effectiveness of intensive management of lipid disorders in 
diabetics in order to reduce the complications. Ahmad N et al 17 performed a study to determine whether patients 
having good glycemic control have better lipid profile than the ones that have poor glycemic control. Out of 78 
diabetic patients having hypertriglyceridemia, 46 patients had poor glycemic control i.e. HbA1c>8%. It was 
established that good glycemic control affects the lipid levels in patients with diabetes type 2. There must be 
sufficient educating of patients in motivating them towards lipid lowering therapy 18. 
Similarly, the clinical trials done by Watts GF 19 and Siddiqui AH et al 20 on association between 
hyperglycemia and risks of coronary disease as a result of dyslipidemia states that in order to achieve better 
results in control of diabetes and prevent its complications, the control of lipid levels in the blood cannot be 
neglected.  
 
Conclusion 
 The study has shown that the prevalence of increased levels of triglycerides is more than increased LDL 
cholesterol levels among these patients. As it has been established that hypertriglyceridemia is a known risk 
factor for causing cardiovascular disorders among diabetic patients, it should be addressed and managed 
accordingly at the onset of diabetes.  
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